La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Integral Diagnostics Gestion
Gestion contrôle des critères 2/4
Le PDG Integral Diagnostics' est Ian Kadish, nommé en May2017, a un mandat de 7.25 ans. La rémunération annuelle totale est A$ 1.10M, composée du salaire de 71.2% et des bonus 28.8%, y compris les actions et options de la société. détient directement 0.24% des actions de la société, d'une valeur de A$ 1.39M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 3.9 ans et 2.1 ans.
Informations clés
Ian Kadish
Directeur général
AU$1.2m
Rémunération totale
Pourcentage du salaire du PDG | 66.3% |
Durée du mandat du directeur général | 7.3yrs |
Propriété du PDG | 0.3% |
Durée moyenne d'occupation des postes de direction | 4.8yrs |
Durée moyenne du mandat des membres du conseil d'administration | 2.2yrs |
Mises à jour récentes de la gestion
Recent updates
Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital
Feb 21Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being
Nov 22Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year
Feb 20These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively
Dec 14Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?
May 26Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year
Feb 28Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate
Feb 25Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why
Oct 29Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?
Sep 13An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued
Jun 04Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?
May 14Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?
May 03We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt
Apr 16Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?
Mar 27Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?
Mar 17The Trends At Integral Diagnostics (ASX:IDX) That You Should Know About
Mar 07Here's What We Like About Integral Diagnostics' (ASX:IDX) Upcoming Dividend
Feb 25Is Integral Diagnostics Limited (ASX:IDX) Popular Amongst Institutions?
Feb 23Have Insiders Been Selling Integral Diagnostics Limited (ASX:IDX) Shares?
Feb 13Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price
Feb 03Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)
Jan 24Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?
Jan 14Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return
Jan 05Is Integral Diagnostics (ASX:IDX) A Risky Investment?
Dec 26At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?
Dec 17What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend
Dec 08Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture
Nov 29Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?
Nov 19Is Integral Diagnostics (ASX:IDX) A Risky Investment?
Sep 20Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Jun 30 2024 | AU$1m | AU$825k | -AU$61m |
Mar 31 2024 | n/a | n/a | -AU$59m |
Dec 31 2023 | n/a | n/a | -AU$58m |
Sep 30 2023 | n/a | n/a | -AU$16m |
Jun 30 2023 | AU$1m | AU$794k | AU$25m |
Mar 31 2023 | n/a | n/a | AU$23m |
Dec 31 2022 | n/a | n/a | AU$21m |
Sep 30 2022 | n/a | n/a | AU$18m |
Jun 30 2022 | n/a | AU$781k | AU$15m |
Mar 31 2022 | n/a | n/a | AU$18m |
Dec 31 2021 | n/a | n/a | AU$22m |
Sep 30 2021 | n/a | n/a | AU$26m |
Jun 30 2021 | AU$2m | AU$736k | AU$31m |
Mar 31 2021 | n/a | n/a | AU$32m |
Dec 31 2020 | n/a | n/a | AU$32m |
Sep 30 2020 | n/a | n/a | AU$28m |
Jun 30 2020 | AU$1m | AU$635k | AU$23m |
Mar 31 2020 | n/a | n/a | AU$22m |
Dec 31 2019 | n/a | n/a | AU$21m |
Sep 30 2019 | n/a | n/a | AU$21m |
Jun 30 2019 | AU$876k | AU$549k | AU$21m |
Mar 31 2019 | n/a | n/a | AU$19m |
Dec 31 2018 | n/a | n/a | AU$17m |
Sep 30 2018 | n/a | n/a | AU$16m |
Jun 30 2018 | AU$711k | AU$489k | AU$15m |
Rémunération vs marché: La rémunération totale de Ian ($USD 739.36K ) est dans la moyenne des entreprises de taille similaire sur le marché Australian ($USD 876.19K ).
Rémunération et revenus: La rémunération de Ian a augmenté alors que l'entreprise n'est pas rentable.
PDG
Ian Kadish (61 yo)
7.3yrs
Titularisation
AU$1,243,752
Compensation
Dr. Ian Kadish, MBBCh, MBA, has been the Chief Executive Officer, Managing Director and Director at Integral Diagnostics Limited since May 22, 2017. Dr. Kadish serves as Independent Non-Executive Director...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
CEO, MD & Director | 7.3yrs | AU$1.24m | 0.25% A$ 1.8m | |
Executive Director | 4.8yrs | AU$1.15m | 0.011% A$ 75.3k | |
Chief Financial Officer | less than a year | pas de données | pas de données | |
Chief Information Officer | 5yrs | pas de données | pas de données | |
Interim Company Secretary | less than a year | pas de données | pas de données |
4.8yrs
Durée moyenne de l'emploi
Gestion expérimentée: L'équipe de direction de IDX est considérée comme expérimentée (ancienneté moyenne 3.9 ans).
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
CEO, MD & Director | no data | AU$1.24m | 0.25% A$ 1.8m | |
Executive Director | 4.8yrs | AU$1.15m | 0.011% A$ 75.3k | |
Independent Non-Executive Director | 6.9yrs | AU$140.53k | 0.013% A$ 92.5k | |
Independent Non-Executive Director | 2.2yrs | AU$137.50k | 0.036% A$ 254.2k | |
Independent Non-Executive Director | 1.1yrs | AU$111.22k | 0.015% A$ 104.6k | |
Independent Non-Executive Chairman | less than a year | AU$168.37k | 0.065% A$ 453.6k |
2.2yrs
Durée moyenne de l'emploi
59yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de IDX ne sont pas considérés comme expérimentés (ancienneté moyenne 2.1 ans), ce qui suggère un nouveau conseil d'administration.